The
TRAILBLAZER
Platform

A revolutionary five-stage pipeline for multicellular immune system modeling. From single-cell data to patient-specific predictions.

01

Data Harmonization

Our Harmonizer NN cleans and annotates single-cell datasets while preserving critical biological signals.

02

Foundation Model

Trained on 60M+ cells to learn universal cellular behavior patterns across diverse tissue types.

03

Cell Type Modeling

Individual models capture specialized behavior of immune cells, tumor cells, and stromal populations.

04

Interaction Network

Multicellular graph captures cell-to-cell communication and microenvironment dynamics.

05

Perturbation Engine

Simulate drug interventions and predict phenotypic shifts at the patient level.

The Full Stack

1

Proprietary Data Loader

100x faster data loading

Ingests massive scRNA-seq datasets instantly.

2

Cell-Type Classifier NN

Hierarchical, best-in-class

Predicts cell type labels on multiple levels of detail.

3

Harmonizer NN

>1000x faster harmonization

Achieves superior batch mixing (high kBET score) indicating effective harmonization without losing biological context.

4

Perturbation NN

>1000x larger context

Predicts gene expression levels of a system of cells with unparalleled accuracy.

5

Phenotype Classifier NN

The decision engine

Predicts the phenotypic state of the patient (drug responsiveness, toxicity, adverse effects).

Why Multicellular Matters

Traditional models treat cells in isolation. TRAILBLAZER captures the full complexity of cell-to-cell interactions that determine treatment response.

Breaking the Quadratic Wall

Current molecular data encoders scale with quadratic time complexity O(n²), limiting modeling to single-cell scale. TRAILBLAZER utilizes a novel architecture with linear time complexity O(n), enabling true multicellular modeling.

CeilingO(n²) - Current TechO(n) - AnubioNumber of Cells (n)Compute Time
Current Technology (O(n²))
TRAILBLAZER (O(n))

See it in action

Explore our validated case studies to see how TRAILBLAZER is transforming immunotherapy research.